Titre : Insulines biphasiques

Insulines biphasiques : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Biphasic Insulins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Insulines biphasiques : Questions médicales les plus fréquentes", "headline": "Insulines biphasiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Insulines biphasiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-08-05", "dateModified": "2026-01-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Insulines biphasiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Association médicamenteuse", "url": "https://questionsmedicales.fr/mesh/D004338", "about": { "@type": "MedicalCondition", "name": "Association médicamenteuse", "code": { "@type": "MedicalCode", "code": "D004338", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.310" } } }, "about": { "@type": "MedicalCondition", "name": "Insulines biphasiques", "alternateName": "Biphasic Insulins", "code": { "@type": "MedicalCode", "code": "D061265", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Roman V Drai", "url": "https://questionsmedicales.fr/author/Roman%20V%20Drai", "affiliation": { "@type": "Organization", "name": "Clinical Trial Department, R&D Center, OOO \"GEROPHARM, Saint Petersburg, Russia." } }, { "@type": "Person", "name": "Bella R Zinnatulina", "url": "https://questionsmedicales.fr/author/Bella%20R%20Zinnatulina", "affiliation": { "@type": "Organization", "name": "Clinical Trial Department, R&D Center, OOO \"GEROPHARM, Saint Petersburg, Russia." } }, { "@type": "Person", "name": "Igor E Makarenko", "url": "https://questionsmedicales.fr/author/Igor%20E%20Makarenko", "affiliation": { "@type": "Organization", "name": "Clinical Trial Department, R&D Center, OOO \"GEROPHARM, Saint Petersburg, Russia." } }, { "@type": "Person", "name": "Wenying Yang", "url": "https://questionsmedicales.fr/author/Wenying%20Yang", "affiliation": { "@type": "Organization", "name": "China-Japan Friendship Hospital, Beijing, China." } }, { "@type": "Person", "name": "Heng Miao", "url": "https://questionsmedicales.fr/author/Heng%20Miao", "affiliation": { "@type": "Organization", "name": "Second Affiliated Hospital of Nanjing Medical University, Nanjing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Bioequivalence of Reference and Biosimilar Preparations of Premixed Biphasic Insulin Aspart: A Comparative Clamp Study.", "datePublished": "2023-09-20", "url": "https://questionsmedicales.fr/article/37728234", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cpdd.1333" } }, { "@type": "ScholarlyArticle", "name": "Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37334526", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dom.15165" } }, { "@type": "ScholarlyArticle", "name": "Biphasic Fermentation of", "datePublished": "2024-03-11", "url": "https://questionsmedicales.fr/article/38542875", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules29061238" } }, { "@type": "ScholarlyArticle", "name": "The Synthesis of Biphasic Metabolites of Carfentanil.", "datePublished": "2023-11-16", "url": "https://questionsmedicales.fr/article/38005347", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules28227625" } }, { "@type": "ScholarlyArticle", "name": "[A curious biphasic breast lesion].", "datePublished": "2024-01-16", "url": "https://questionsmedicales.fr/article/38233235", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.annpat.2023.12.011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Préparations pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/D004364" }, { "@type": "ListItem", "position": 3, "name": "Association médicamenteuse", "item": "https://questionsmedicales.fr/mesh/D004338" }, { "@type": "ListItem", "position": 4, "name": "Insulines biphasiques", "item": "https://questionsmedicales.fr/mesh/D061265" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Insulines biphasiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Insulines biphasiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Insulines biphasiques", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D061265#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 27/01/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Roman V Drai

2 publications dans cette catégorie

Affiliations :
  • Clinical Trial Department, R&D Center, OOO "GEROPHARM, Saint Petersburg, Russia.
Publications dans "Insulines biphasiques" :

Bella R Zinnatulina

2 publications dans cette catégorie

Affiliations :
  • Clinical Trial Department, R&D Center, OOO "GEROPHARM, Saint Petersburg, Russia.
Publications dans "Insulines biphasiques" :

Igor E Makarenko

2 publications dans cette catégorie

Affiliations :
  • Clinical Trial Department, R&D Center, OOO "GEROPHARM, Saint Petersburg, Russia.
Publications dans "Insulines biphasiques" :

Jun Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Endocrinology, Shanghai Fifth People's Hospital Affiliated to Fudan University, 801 Heqing Road, Minhang District, Shanghai 200240, China.

Peng Zhang

2 publications dans cette catégorie

Affiliations :
  • Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Shenzhen Engineering Research Center for Medical Bioactive Materials, Shenzhen, China.
  • University of Chinese Academy of Sciences, Beijing, China.
Publications dans "Insulines biphasiques" :

Ting Wang

2 publications dans cette catégorie

Affiliations :
  • Department of Clinical Laboratory and Hematology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China, Zhenjiang, Jiangsu 212013, PR China.
Publications dans "Insulines biphasiques" :

Victoria S Kulesh

1 publication dans cette catégorie

Affiliations :
  • Clinical Trial Department, R&D Center, OOO "GEROPHARM, Saint Petersburg, Russia.
  • I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Publications dans "Insulines biphasiques" :

Fedor G Pilyus

1 publication dans cette catégorie

Affiliations :
  • I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Publications dans "Insulines biphasiques" :

Alexander L Khokhlov

1 publication dans cette catégorie

Affiliations :
  • Department of Clinical Pharmacology, Yaroslavl State Medical University, Yaroslavl, Russia.
Publications dans "Insulines biphasiques" :

Nesreen A Saadeh

1 publication dans cette catégorie

Affiliations :
  • Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, P.O.Box 3030, Irbid, 22110, Jordan. nasaadeh@just.edu.jo.
Publications dans "Insulines biphasiques" :

Ola Y Al-Azzeh

1 publication dans cette catégorie

Affiliations :
  • Pharmacy Practice Department, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Publications dans "Insulines biphasiques" :

Yousef S Khader

1 publication dans cette catégorie

Affiliations :
  • Department of Community Medicine, Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Publications dans "Insulines biphasiques" :

David Siegel

1 publication dans cette catégorie

Affiliations :
  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Publications dans "Insulines biphasiques" :

Serapio M Baca

1 publication dans cette catégorie

Affiliations :
  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Publications dans "Insulines biphasiques" :

Sources (4451 au total)

Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England.

This study investigated the ethnic differences in glycaemic levels and clinical characteristics among insulin-naïve people with type 2 diabetes (T2D) initiating biphasic insulin aspart 30/70 (BIAsp 30... Retrospective, observational cohort study utilizing data from the Clinical Practice Research Datalink Aurum database, including White, South Asian, Black and Chinese insulin-naïve adults with T2D, ini... In total, 11 186 eligible people were selected (9443 White, 1116 South Asian, 594 Black, 33 Chinese). HbA1c decreased across all subgroups 6 months post index: estimated %-point changes [95% CI of -2.... Among insulin-naïve people with T2D initiating BIAsp 30, clinically meaningful HbA1c reductions in all ethnicities were observed. Some ethnic groups had larger reductions than others, but differences ...

Biphasic Fermentation of

In this study, we optimized the solid-state fermentation process of... Optimal fermentation conditions comprised a duration of 2 days, a temperature of 14 °C, and a humidity of 77%. The peak water extract yield and DPPH free radical scavenging rate of the water extract f... Biphasic fermentation of...

Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes.

Combining insulin with a glucagon-like peptide-1 receptor agonist (GLP-1RA) to treat type 2 diabetes (T2D) is common. While many studies have investigated concomitant therapy with basal insulin+GLP-1R... This retrospective cohort study with propensity score matching assessed glycaemic levels and other clinical outcomes in people with T2D, comparing biphasic insulin aspart 30/70 (BIAsp 30) + GLP-1RA wi... In total, 4770 eligible people were identified; 1511 had a BIAsp 30 + GLP-1RA regimen and were propensity score-matched to an equal number receiving basal+GLP-1RA. There was no significant difference ... Combining BIAsp 30 + GLP-1RA provides glycaemic control with no significant difference to that of propensity score-matched people receiving basal insulin+GLP-1RA, with no increase in hypoglycaemia ris...